Skip to main content

Table 1 Clinical characteristics and outcomes of patients in the success group

From: Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study

Case No.GenderAge (yo)Cause of ARDSBaseline PaO2/FiO2 (mmHg)SpO2 (%)PaO2/FiO2 with HFNCPaO2/FiO2 with HFNC+PPPaO2/FiO2 with NIVPaO2/FiO2 with NIV+PPIntubationECMOOutcome
1Male43Influenza16095108144160 NoNoSurvive
2Male49Pneumonia without pathogen10993 108109152NoNoSurvive
3Male37Viral Pneumonia117955987117 NoNoSurvive
4Male61Pneumonia without pathogen17096115168170 NoNoSurvive
5Male43Influenza14193  141173NoNoSurvive
6Male56Influenza1429594100142 NoNoSurvive
7Female54Influenza 9299151  NoNoSurvive
8Male30Pneumonia without pathogen16896  168174NoNoSurvive
9Male40Pneumonia without pathogen16796  16790NoNoSurvive
10Female54Pneumonia without pathogen6395 63 150NoNoSurvive
11Female48Influenza23796 178237 NoNoSurvive
  1. ARDS acute respiratory distress syndrome, NIV non-invasive ventilation, HFNC high flow nasal cannula, PP prone position, ECMO extracorporeal membrane oxygenation